• ¹«ÖÚºÅ

    european pharmacopoeia 5.0

    ÿÌì»ñÈ¡Ãâ·Ñ֪ʶ

  • ÊÓÆµºÅ

    european pharmacopoeia 5.0

    ɨһɨÃâ·Ñ¹Û¿´ÊÓÆµ

    -->
  • Ö±²¥Æ½Ì¨

    european pharmacopoeia 5.0

    ½øÈëÊÓÆµÖ±²¥Æ½Ì¨

  • ×¢²á»áÔ±

  • european pharmacopoeia 5.0 ÁªÏµ¿Í·þ
    european pharmacopoeia 5.0 µã»÷ÁªÏµ¿Í·þ

    ÔÚÏßʱ¼ä£º9:00-18:00

    ¿Í·þ΢ÐÅ

    xiaoniba95

    µç×ÓÓʼþ

    coolgou1987@126.com
  • european pharmacopoeia 5.0 ¿Í·þ΢ÐÅ

    ɨÃè¶þάÂë

    Ìí¼Ó¿Í·þ΢ÐźÅ

    european pharmacopoeia 5.0
  • european pharmacopoeia 5.0 APPÏÂÔØ

    ÖÆÀäAPP

    ÖÆÀä°Ù¼ÒÍøÂç´óѧ

    european pharmacopoeia 5.0
  • european pharmacopoeia 5.0 ΢ÐŹ«ÖÚ

    ɨÃè¶þάÂë

    ¹Ø×¢ÖÆÀä°Ù¼Ò΢ÐŹ«ÖÚºÅ

    european pharmacopoeia 5.0

European Pharmacopoeia 5.0 -

Dedicated exclusively to individual substance monographs, including active pharmaceutical ingredients (APIs) and excipients. European Pharmacopoeia | EUR-Lex

The most defining characteristic of Ph. Eur. 5.0 was its alignment with the Q3, Q4, and Q6 guidelines.

¹Ø±Õ

Õ¾³¤ÍƼö¿Î³Ì ÉÏÒ»Ìõ /1 ÏÂÒ»Ìõ

ÖÆÀäÐÐÒµÔÚÏßѧϰƽ̨
×Ê ÁÏ Éê Ã÷
±¾ÍøÕ¾Ö»×ö×ÊÁÏÊÕ¼¯ºÍÕûÀí
ÕûÀí²»Ò×£¬½ÓÊÜ×ÔÔ¸´òÉÍ

European Pharmacopoeia 5.0 -

european pharmacopoeia 5.0 ÔÚÏßQQ×Éѯ
{360×Ô¶¯ÊÕ¼;}